Equites Radar

ACHC · Acadia Healthcare Company, Inc.

Medical Care FacilitiesUnited StatesAnalyst view: Buy

$34.51

+0.58% last session

End-of-day data · updated 2026-07-28

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Buy (2.00 from 14 analysts)
To mean target: -6.7%

Market cap

$3B

Enterprise value

$6B

Trailing P/E

Forward P/E

18.5

Dividend yield

Beta

0.64

Avg volume

3M

Employees

25K

2D change

-5.82%

5D change

-4.44%

10D change

-5.80%

30D change

18.53%

60D change

40.09%

MTD change

4.00%

YTD change

129.03%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)2.00
Covering analysts14
Mean price target$32.21
Low price target$13.00
Upside to mean target-6.7%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)57.9
50-day MA$27.70
200-day MA$21.81
Price vs 50-day MA+18.0%
Price vs 200-day MA+49.9%
MACD histogram-0.14
Volume vs 3-month avg1.4×
52w low $11.6852w high $35.61

Analyst sentiment over time — ACHC

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-20

Latest call per bank · past 12 months

UBS

Buy

$39.00

+13.0% vs price
▲ raised from $31.00Maintains · 2026-07-09

Jefferies

Buy

$30.00

-13.1% vs price
▲ raised from $24.50Upgrade · 2026-06-03

RBC Capital

Outperform

$31.00

-10.2% vs price
▲ raised from $28.00Maintains · 2026-05-04

Barclays

Equal-Weight

$25.00

-27.6% vs price
▲ raised from $20.00Maintains · 2026-05-01

Deutsche Bank

Buy

$20.00

-42.0% vs price
▼ cut from $33.00Maintains · 2025-12-03

Bank of America

Underperform

$13.00

-62.3% vs price
▼ cut from $21.50Downgrade · 2025-12-03

Recent rating actions

DateFirmActionRatingPrice target
2026-07-20GuggenheimMaintainsBuy$31.00 $38.00
2026-07-20GuggenheimMaintainsBuy$145 $150
2026-07-14TD CowenMaintainsBuy$30.00 $36.00
2026-07-14KeybancMaintainsOverweight$30.00 $40.00
2026-07-09UBSMaintainsBuy$31.00 $39.00
2026-06-03JefferiesUpgradeHoldBuy$24.50 $30.00
2026-05-04RBC CapitalMaintainsOutperform$28.00 $31.00
2026-05-04GuggenheimMaintainsBuy$26.00 $31.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 58 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 18.0% above the 50-day MA ($27.70).
  • Price vs 200-day MA: Trading 49.9% above the 200-day MA ($21.81).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.14) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($11.68) and high ($35.61).

ACHC Price Chart

Loading chart for ACHC

Fundamentals

Revenue (TTM)$3.0B
EBITDA$1.0B
Free cash flow$0M
Operating cash flow$0M
Book value / share$21.58
Net debt / EBITDA4.3
WACC7.0%
Revenue growth8.00%
Earnings growth-50.00%

About Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

More in Medical Care Facilities

Screen ACHC against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.